Pharmacann
Health Care
Based in IL
🤖
AI Overview
With $655K in lobbying spend across 24 quarterly filings, Pharmacann is an active lobbying client. Their lobbying covers 7 issue areas. Active from 2018 to 2023.
$655K
Total Spend
6
Years Active
1
Firms Hired
1
Lobbyists Deployed
7
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $75K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
| 2022 | $180K |
| 2023 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Pharmacann disclosed contacting in their lobbying filings.
HOUSE OF REPRESENTATIVESSENATEAgriculture, Dept of (USDA)Environmental Protection Agency (EPA)
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Veterans, Health Issues, Banking, Financial and 2 more
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Follow the Money
Tracking lobbying dollars through the financial system.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.